Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Evoke Pharma Inc EVOK

Healthcare
Evoke Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of drugs to treat gastrointestinal (GI) disorders and diseases. The Company operates through the development and commercialization of pharmaceutical products. It is developing its product, Gimoti (metoclopramide) nasal spray, the first and only nasally administered... see more

Recent & Breaking News (NDAQ:EVOK)

Research Reports Coverage on Generic Drugs Stocks -- Evoke Pharma, Catalyst Pharma, Neurocrine Biosciences, and Galectin Therapeutics

PR Newswire October 31, 2016

18 Biggest Mid-Day Gainers For Wednesday

Benzinga.com  September 7, 2016

Evoke Pharma Announces Positive Non-Clinical Pre-NDA Meeting with FDA for Gimoti

GlobeNewswire September 7, 2016

Evoke Pharma to Present at Rodman & Renshaw 18th Annual Global Investment Conference

GlobeNewswire September 6, 2016

Evoke Pharma Reports Second Quarter 2016 Results

GlobeNewswire August 15, 2016

Evoke Pharma Schedules Webcast and Conference Call for Second Quarter 2016 Financial Results

GlobeNewswire August 10, 2016

Evoke Pharma Completes Credit Facility Repayment

GlobeNewswire August 8, 2016

Evoke Pharma Announces $10 Million Registered Direct Offering Priced At-The-Market

GlobeNewswire July 29, 2016

20 Biggest Mid-Day Gainers For Friday

Benzinga.com  July 29, 2016

20 Biggest Mid-Day Gainers For Thursday

Benzinga.com  July 28, 2016

Evoke Pharma Receives Conditional FDA Acceptance of Proposed Brand Name for EVK-001

GlobeNewswire July 26, 2016

10 Biggest Mid-Day Losers For Wednesday

Benzinga.com  July 20, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  July 20, 2016

Evoke Pharma Announces $4.5 Million At-The-Market Offering

GlobeNewswire July 20, 2016

Mid-Afternoon Market Update: Evoke Pharma Drops On Failed Phase 3 EVK-001 Data; ParkerVision Shares Spike Higher

Benzinga.com  July 18, 2016

Mid-Morning Market Update: Markets Mostly Higher; Bank of America Tops Q2 Expectations

Benzinga.com  July 18, 2016

Evoke Pharma's Phase 3 Clinical Trial Of EVK-001 Fails To Achieve Primary Endpoint

Benzinga.com  July 18, 2016

Evoke Pharma Reports Topline Results from EVK-001 Phase 3 Clinical Trial

GlobeNewswire July 18, 2016

Evoke Advances Commercial Preparations for EVK-001 with inVentiv Agreement

GlobeNewswire July 7, 2016

Evoke Completes Phase 3 Clinical Trial of EVK-001 in Women with Symptoms Associated with Diabetic Gastroparesis

GlobeNewswire June 1, 2016